Clinical trial

Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast Cancer

NCT03495544

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2018-01-01

PhaseN/A

Study timeline

Study start (actual)2018-01-01Date precision: day

Registry last updated2018-04-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hereditary Breast Cancerunresolved

Interventions

PD-L1 expressionDIAGNOSTIC_TEST

Sponsors & collaborators

Tatarstan Cancer Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03495544 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.